{"id":12000,"date":"2025-05-15T07:00:00","date_gmt":"2025-05-15T05:00:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/"},"modified":"2025-05-15T07:00:00","modified_gmt":"2025-05-15T05:00:00","slug":"irlab-presenterar-pa-biostock-global-forum-2025","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/","title":{"rendered":"IRLAB presenterar p\u00e5 BioStock Global Forum 2025"},"content":{"rendered":"
\n

G\u00f6teborg, den 15 maj, 2025 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar av Parkinsons sjukdom, meddelar idag att vd Kristina Torfg\u00e5rd kommer att presentera IRLAB inf\u00f6r potentiella partners och specialistinvesterare inom life science p\u00e5 BioStock Global Forum 2025. Eventet \u00e4ger rum den 20-21 maj i Lund.<\/strong><\/p>\n<\/div>\n

\n

P\u00e5 m\u00f6tet medverkar b\u00e5de svenska och internationella investerare och potentiella partners i l\u00e4kemedelsindustrin vilket ger bolaget goda m\u00f6jligheter att utvidga sitt n\u00e4tverk och knyta nya kontakter.<\/p>\n

Kristina Torfg\u00e5rd, vd, presenterar bolaget kl. 15:30 den 21 maj. IRLAB:s presentation kommer att filmas och finnas tillg\u00e4nglig i efterhand via Biostocks hemsida och sociala medier.<\/p>\n

Mer information om m\u00f6tet: https:\/\/www.biostock.se\/globalforum2025\/<\/a><\/p>\n<\/div>\n

\n

F\u00f6r mer information<\/strong><\/p>\n

\n

Kristina Torfg\u00e5rd, VD
Tel: +46 730 60 70 99
E-post: kristina.torfgard@irlab.se<\/a><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

\n

IRLAB uppt\u00e4cker och utvecklar en portf\u00f6lj av transformativa behandlingar f\u00f6r alla stadier av Parkinsons sjukdom. Bolaget har sitt ursprung i Nobelpristagaren Prof. Arvid Carlssons forskargrupp och uppt\u00e4ckten av ett samband mellan st\u00f6rningar i hj\u00e4rnans signalsubstanser och hj\u00e4rnans sjukdomar. Mesdopetam (IRL790), under utveckling f\u00f6r behandling av levodopa-inducerade dyskinesier, har slutf\u00f6rt Fas IIb och \u00e4r i f\u00f6rberedelse f\u00f6r Fas III. Pirepemat (IRL752), befinner sig f\u00f6r n\u00e4rvarande i Fas IIb, och utv\u00e4rderas f\u00f6r sin effekt p\u00e5 balans och fallfrekvens vid Parkinson. IRL757, en substans som utvecklas f\u00f6r behandling av apati vid neurodegenerativa sjukdomar, befinner sig i Fas I. Dessutom utvecklar bolaget de tv\u00e5 prekliniska programmen IRL942 och IRL1117 mot Fas I-studier. IRLAB:s pipeline har genererats av bolagets egenutvecklade systembiologibaserade forskningsplattform Integrative Screening Process (ISP). IRLAB har sitt huvudkontor i Sverige och \u00e4r noterat p\u00e5 Nasdaq Stockholm (IRLAB A). F\u00f6r mer information, bes\u00f6k\u00a0www.irlab.se<\/a>.<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

IRLAB presenterar p\u00e5 BioStock Global Forum 2025<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

G\u00f6teborg, den 15 maj, 2025 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar av Parkinsons sjukdom, meddelar idag att vd Kristina Torfg\u00e5rd kommer att presentera IRLAB inf\u00f6r potentiella partners och specialistinvesterare inom life science p\u00e5 BioStock Global Forum 2025. Eventet \u00e4ger rum den 20-21 maj i Lund.<\/p>\n","protected":false},"template":"","class_list":["post-12000","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB presenterar p\u00e5 BioStock Global Forum 2025 - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB presenterar p\u00e5 BioStock Global Forum 2025 - IRLAB\" \/>\n<meta property=\"og:description\" content=\"G\u00f6teborg, den 15 maj, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar av Parkinsons sjukdom, meddelar idag att vd Kristina Torfg\u00e5rd kommer att presentera IRLAB inf\u00f6r potentiella partners och specialistinvesterare inom life science p\u00e5 BioStock Global Forum 2025. Eventet \u00e4ger rum den 20-21 maj i Lund.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/\",\"url\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/\",\"name\":\"IRLAB presenterar p\u00e5 BioStock Global Forum 2025 - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2025-05-15T05:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB presenterar p\u00e5 BioStock Global Forum 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB presenterar p\u00e5 BioStock Global Forum 2025 - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB presenterar p\u00e5 BioStock Global Forum 2025 - IRLAB","og_description":"G\u00f6teborg, den 15 maj, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar av Parkinsons sjukdom, meddelar idag att vd Kristina Torfg\u00e5rd kommer att presentera IRLAB inf\u00f6r potentiella partners och specialistinvesterare inom life science p\u00e5 BioStock Global Forum 2025. Eventet \u00e4ger rum den 20-21 maj i Lund.","og_url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/","url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/","name":"IRLAB presenterar p\u00e5 BioStock Global Forum 2025 - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2025-05-15T05:00:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-biostock-global-forum-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB presenterar p\u00e5 BioStock Global Forum 2025"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/12000","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=12000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}